Synalgos-DC 16 mg / 356.4 mg / 30 mg Oral Capsule
RxNorm 1234976
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1234976 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Synalgos-DC 16 mg / 356.4 mg / 30 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
ASA 356.4 mg / Caffeine 30 mg / dihydrocodeine bitartrate 16 mg Oral Capsule [Synalgos-DC]
(Atom ID: 5496198)
SBD
Semantic Branded Drug (SBD):
Aspirin 356.4 mg / caffeine 30 mg / dihydrocodeine bitartrate 16 mg Oral Capsule [Synalgos-DC]
(Atom ID: 12360913)
SY
Synonym (SY):
Synalgos-DC (ASA 356.4 mg / caffeine 30 mg / dihydrocodeine bitartrate 16 mg) Oral Capsule
(Atom ID: 4225209)
PSN